peripheral arterial disease Articles
-
Pressure Ulcer - Case study
Patient History Patient presented with a history of hypertension, hyperlipidemia, peripheral arterial disease, obesity, arterial fibrillation, and transient ischemic attack. Patient had total knee replacement surgery and developed a complication due to improper off-loading, developing pressure ulcer on the right heel. Patient was treated with collagen products and wet to dry dressings prior to ...
-
Arterial reconstruction with human bioengineered acellular blood vessels in patients with peripheral arterial disease
Abstract Objective: Vascular conduit is essential for arterial reconstruction for a number of conditions, including trauma and atherosclerotic occlusive disease. We have developed a tissue-engineered human acellular vessel (HAV) that can be manufactured, stored on site at hospitals, and be immediately available for arterial vascular reconstruction. Although the HAV is acellular when implanted, ...
-
Innovation Spotlight: Alucent Biomedical | Can we Make ‘Stents’ Obsolete?
As part of our ongoing Vascular Innovation Series in conjunction with The Way to My Heart, journalist Kym McNicholas interviewed Alucent Biomedical CEO, Dr. Myles Greenberg. Treatment for vascular blockages is getting a much-needed innovation makeover. Alucent’s first area of focus is one the most debilitating vascular diseases –peripheral artery disease, plaque build-up in mainly ...
-
Philips to further expand its image-guided therapy devices portfolio through acquisition of Vesper Medical
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has signed an agreement to acquire Vesper Medical Inc., a US-based medical technology company that develops minimally-invasive peripheral vascular devices. Vesper Medical will further expand Philips’ portfolio of diagnostic and therapeutic devices ...
-
Lower Extremity Amputations: Why, What Kind, & Life After
Every year, surgeons perform a lower-limb amputation due specifically to diabetes on approximately 73,000 patients in the US alone. Annually there are over 1 million limb amputations worldwide. Most of these amputations are performed for the treatment of non-healing diabetic foot ulcers that resulted from PAD (Peripheral Arterial Disease). These non-healing foot ulcers are caused by high blood ...
By EO2 Concepts
-
Alucent Biomedical Re-Envisioning PAD Treatment with a Natural Vascular Scaffold
Start-up Alucent Biomedical is using a light-activated molecule, delivered via a balloon catheter, to create a natural vascular scaffold in diseased peripheral vessels, with the aim of providing a long-lasting treatment option that maintains patency while leaving nothing behind in the vessel. Alucent Biomedical Inc. is rethinking peripheral artery disease (PAD) treatment with a novel natural ...
-
Stepping Into 2021 with a Fresh Start: 7 Habits for Highly Effective Wound Care
As we begin this New Year we have an opportunity to begin with a fresh start as we pursue our passion to promote and speed the healing of wounds! Our role as Wound Care Clinicians has risen to a whole new level of essential care for an extremely high risk population. In this current Covid-19 climate that we are living in, we are all facing challenges that we have never dealt with before. ...
By EO2 Concepts
-
Cost-Effectiveness of Percutaneous Deep Vein Arterialization for Patients with No-Option Chronic Limb-Threatening Ischemia: an Exploratory Analysis Based on the PROMISE I Study
Abstract Background. As the most advanced stage of peripheral arterial disease (PAD), chronic limb-threatening ischemia (CLTI) is associated with a high risk of lower-limb loss and mortality. Percutaneous deep vein arterialization (pDVA) is a promising new treatment alternative for CLTI patients who cannot be treated with conventional revascularization techniques. Our study objective was to ...
-
The Evolving Role of Percutaneous Deep Venous Arterialization
The increasing incidence of peripheral artery disease (PAD) is occurring globally as populations age and rates of diabetes, obesity, and renal disease increase.1-3 Although most of these patients have no symptoms, when the disease progresses to its most advanced form, chronic limb-threatening ischemia (CLTI), there is a significant risk for limb loss. Despite the fact that our revascularization ...
-
LimFlow Percutaneous Deep Venous Arterialization
What interested you in LimFlow, and how did you get involved in the PROMISE I trial? Dr. Clair: Practicing vascular surgery, where a number of patients are evaluated for chronic limb-threatening ischemia (CLTI), you are guaranteed to have patients who are not candidates for percutaneous or surgical revascularization. These patients often have arterial systems open or identifiable to the ankle, ...
-
Different Types of Limb Loss: Before & After Surgery
Before a patient can get fit with their multi-articulating myoelectric hand, it’s vital that their prosthetist conducts a thorough evaluation and understands the cause of amputation or limb loss. This information helps prosthetists understand what a patient’s needs are so they can determine which prosthetic hand is the best fit for them. With this in mind, we’ll discuss the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you